In their article in this issue of the Journal of Neurosurgery, Friedman and colleagues add to the neurosurgical literature by detailing their experience with linear acceleratorbased radiosurgery in 390 patients with VSs. The 5-year actuarial tumor control rate was 90%. They noted a 4.4% rate of facial weakness and a 3.6% risk of numbness following radiosurgery. After adopting a prescription dose rate of 12.5 Gy, rates of facial weakness and numbness each decreased to 0.7%.
Unfortunately, their study does not include data on the rate of hearing preservation. With the proliferation of magnetic resonance imaging and increased awareness of this neuropathological entity, more and more patients with VS have serviceable hearing at the time of diagnosis and initial treatment. In my experience, one of the patient's first questions is typically about the chance of hearing preservation after radiosurgery.
At the University of Virginia, more than 400 patients with VSs have been treated with Gamma Knife surgery (GKS); the results of some of these cases have been reported previously. 12 Among patients treated primarily with GKS a decrease in tumor size was seen in 81%, no change in 13%, and an increase in 6%. In patients treated with GKS after microsurgery, a decrease in tumor size occurred in 65%, no change in 25%, and an increase in 10%. Notably, although our experience in treating large VSs (that is, tumors Ն 3 cm in diameter) is minimal, we have observed a 95% tumor control rate in such cases after GKS. Such a result for these large lesions in patients unfit for microsurgery was unexpected.
Among the patients at the University of Virginia, permanent changes in trigeminal sensation occurred in 1.7% and facial paresis occurred in 1.5%. Of the patients with useful hearing before GKS, 58% retained it after radiosurgery, 42% experienced some degree of deterioration, and 31% lost useful hearing. The majority of hearing changes were observed at the 2-year checkup, although some patients experienced auditory changes as late as 8 years postradiosurgery. Authors at other centers have reported similar rates of tumor control, hearing preservation, and complications.
See the corresponding article in this issue, pp 657-661.
or hydrocephalus requiring spinal fluid diversion after radiosurgery for a VS, although both of these complications have been reported elsewhere. 3, 11 Although radiation-induced neoplasia after GKS for VS has not been seen at the University of Virginia, we have observed radiosurgically induced meningiomas in two patients treated for arteriovenous malformations. Other researchers have reported malignant transformation or malignant tumorigenesis after the treatment of VS. 5, 13, 14 Fortunately, the risks of cerebellar edema, hydrocephalus, or neoplasia following radiosurgery in patients with VS appear quite low.
Radiosurgery has substantially altered the treatment paradigm for many patients with VSs, and the work by Friedman and colleagues affirms radiosurgery's significance in the neurosurgical armamentarium. Despite the favorable risk-benefit profile for radiosurgery, a trained neurosurgeon must thoroughly evaluate a patient clinically and radiologically. In addition, a neurosurgeon must factor the patient's expectations into the equation before advising a microsurgical or radiosurgical approach. Regardless of the approach taken, patients must have open-ended clinical and neuroimaging follow ups to evaluate the tumor's response to surgery, assess complications, and provide additional treatment as needed.
RESPONSE: We agree completely with Dr. Sheehan's thoughtful comments about radiosurgery for VSs. Based on extensive experience with surgery and radiosurgery for these tumors, we believe that radiosurgery is the treatment of choice for small tumors (Ͻ 3 cm). We make this assertion because the long-term tumor control rates (90% of tumors were unchanged or smaller; 99% required no further surgical intervention during the follow up) and the cranial nerve morbidity rates (0.7% with doses used since 1994) greatly exceed the published results of even the most experienced surgeons. The issue of malignant tumorigenesis has recently been the subject of much discussion. It probably exists but at a frequency tremendously lower than the risk of a serious complication from open surgery. Let's use our hard-won microsurgical skills on larger tumors and accept the facts about radiosurgery discussed in our paper and many others. University of Florida Gainesville, Florida
